Clinical Trials for Radiotherapy

Find clinical trials for radiotherapy. Discover research opportunities and treatment options in your area.

104 Active Trials Found

Showing 104 trials on this page

Page 1 of 6

Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors

NCT ID: NCT07058948

This clinical trial is studying a new way to treat advanced solid tumors, including lung cancer, by combining a special type of radiation therapy called lattice radiation therapy (LRT) with immunot...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, Tianjin, China

Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC

NCT ID: NCT05754203

This clinical trial is exploring a new treatment approach for patients with advanced non-small cell lung cancer (NSCLC). Researchers are combining a special type of radiation therapy, called super-...

Recruiting

Phase: NA Type: interventional Locations: Chongqing, Chongqing, China, Chongqing, , China

Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer

NCT ID: NCT05909137

This clinical trial is studying a new approach to treating advanced non-small cell lung cancer (NSCLC) that cannot be surgically removed, specifically focusing on whether it's safe to skip a part o...

Not yet recruiting

Type: observational

BRAVE Study: QL1706 + Bevacizumab + SBRT for BCLC-C HCC With PVTT or Oligometastases

NCT ID: NCT07062055

This clinical trial, called the BRAVE Study, is exploring a new treatment approach for people with advanced liver cancer (hepatocellular carcinoma) who have cancer growing into the main vein of the...

Recruiting

Phase: PHASE2 Type: interventional Locations: Jinan, Shandong, China

Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors

NCT ID: NCT07071103

This clinical trial is studying a new treatment approach for patients with advanced cancers that have spread to other parts of the body and have not responded well to previous immunotherapy treatme...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shantou, Guangdong, China

Study of Peripheral Blood CHI3L1 to Predict Tumor Response to Radiotherapy

NCT ID: NCT07071688

This clinical trial is studying whether a blood test measuring a protein called CHI3L1 can help predict how well tumors respond to radiotherapy, a common cancer treatment that uses radiation to kil...

Not yet recruiting

Type: observational Locations: Guangzhou, Guangzhou, China, Huizhou, , China +1 more

Nutritional Status of Head and Neck Cancer Patients

NCT ID: NCT07068711

This clinical trial is studying how the nutrition and overall health of people with head and neck cancer change while they are receiving radiotherapy treatment. The researchers will regularly check...

Recruiting

Type: observational Locations: Istanbul, Pendik, Turkey

A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases

NCT ID: NCT04299646

This clinical trial is investigating a treatment called stereotactic radiotherapy (SRT) for patients with metastatic renal cell carcinoma (RCC) who are experiencing a specific type of disease progr...

Recruiting

Phase: PHASE2 Type: interventional Locations: Villejuif, , France, Metz, , France +29 more

Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.

NCT ID: NCT06903312

This clinical trial is designed to investigate whether treating the primary kidney tumor in patients with metastatic renal cell carcinoma (mRCC) who are responding well to immunotherapy can help th...

Recruiting

Phase: PHASE4 Type: interventional Locations: Roma, , Italy

Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

NCT ID: NCT06841172

This clinical trial is investigating the best way to treat patients with a type of liver cancer called hepatocellular carcinoma (HCC) who are experiencing limited disease progression, known as olig...

Recruiting

Phase: PHASE3 Type: interventional Locations: Jinan, Shandong, China

Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases

NCT ID: NCT06356584

This clinical trial is exploring a new treatment approach for advanced metastatic colorectal cancer (CRC), which is cancer that has spread beyond the colon and rectum. The study is testing a combin...

Recruiting

Phase: PHASE2 Type: interventional Locations: Jinan, Shandong, China

The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)

NCT ID: NCT07038304

This clinical trial is studying whether a targeted type of radiotherapy, called Metastatic Directed Radiotherapy (MDRT), can help men with a specific type of advanced prostate cancer. This cancer h...

Recruiting

Phase: PHASE2 Type: interventional Locations: Groningen, , Netherlands, Nijmegen, , Netherlands

Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma

NCT ID: NCT06168292

This clinical trial is exploring a new treatment option for patients with a specific type of bile duct cancer called extrahepatic cholangiocarcinoma, which cannot be treated with surgery. The study...

Recruiting

Phase: NA Type: interventional Locations: Goyang Si, Other, Korea, Republic Of

Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study

NCT ID: NCT07020247

The PALACE Study is a clinical trial looking at how effective a personalized treatment combining long-course radiotherapy and chemotherapy is for patients with locally advanced rectal cancer (LARC)...

Recruiting

Phase: PHASE3 Type: interventional Locations: Chengdu, Sichuan, China

Photon Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC

NCT ID: NCT06999707

This clinical trial is studying a combination treatment for patients with unresectable hepatocellular carcinoma (HCC), a type of liver cancer that can't be removed by surgery. Researchers are looki...

Recruiting

Phase: PHASE2 Type: interventional Locations: Taoyuan City, , Taiwan

A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

NCT ID: NCT05417516

The RAPID2 trial is studying a treatment option for women with early-stage breast cancer. Specifically, it is comparing two types of radiation therapy: Partial Breast Irradiation (PBI), which targe...

Recruiting

Phase: PHASE3 Type: interventional Locations: Toronto, Ontario, Canada, Saskatoon, Saskatchewan, Canada +51 more

Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor in Metastatic pMMR/MSS Colorectal Cancer (MODIFI-CRC)

NCT ID: NCT06958419

The MODIFI-CRC clinical trial is investigating a new treatment approach for patients with metastatic colorectal cancer, which means the cancer has spread beyond the colon or rectum. This study aims...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

Node-Sparing Short-Course Radiotherapy Plus First-Line Therapy and PD-1 Inhibitor in Unresectable/Metastastic pMMR/MSS Gastric Cancer (MODIFI-GC)

NCT ID: NCT06980389

The MODIFI-GC clinical trial is investigating a new treatment approach for patients with advanced gastric cancer that cannot be surgically removed. This trial combines a specific type of short radi...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II)

NCT ID: NCT06958432

The MODIFI-RC-II clinical trial is studying a new treatment approach for patients with a specific type of rectal cancer known as mid/low microsatellite stable (MSS) or proficient mismatch repair (p...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

Dietary Supplements to Treat Radiation-Induced Rectal Injury

NCT ID: NCT06776016

This clinical trial is studying the effects of a dietary supplement called tributyrin (TB) to help treat rectal problems caused by radiation therapy, a condition known as radiation-induced rectal i...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China, Guangzhou, Guangdong, China +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions